President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines.
Category: Sandoz International GmbH
-
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
-
How Trump’s ‘Liberation Day’ Tariffs Might Go Down
The president is set to announce details of his sweeping tariffs, as companies and global trading partners scramble to respond.